Literature DB >> 29199383

Combined corticosterone treatment and chronic restraint stress lead to depression associated with early cognitive deficits in mice.

Gwladys Temkou Ngoupaye1,2, Francis Bray Yassi3, Doriane Amanda Nguepi Bahane3, Elisabeth Ngo Bum3,4.   

Abstract

Many models, such as chronic mild stress, chronic stress or chronic corticosterone injections are used to induce depression associated with cognitive deficits. However, the induction period in these different models is still long and face constraints when it is short such as in the chronic mild stress done in a minimum period of 21 days. This study aimed to characterize a model of depression with early onset cognitive deficit. 14 days combined chronic injection of corticosterone followed by 2 h restraint stress using a restrainer was used to induce depression with early cognitive deficit onset. The forced swim test, sucrose test and plasma corticosterone concentration were used to assess depression-like characteristics. The Morris water maze, novel object recognition task, as well as hippocampal acetylcholinesterase activity were used to assess cognitive deficit. The combined corticosterone injection + chronic restraint stress group presented with marked depression-like behaviour and a higher plasma corticosterone concentration compared to corticosterone injection alone and restraint stress alone. It also showed an alteration in the learning process, memory deficit as well as increased acetylcholinesterase activity compared to corticosterone injection and restraint stress alone groups. These findings suggest that the combined corticosterone administration and chronic restraint stress can be used not only as an animal model for severe depression, but also for depression with early onset cognitive deficit.

Entities:  

Keywords:  Acetylcholinesterase; Cognitive deficit; Corticosterone; Depression; Memory; Restraint

Mesh:

Substances:

Year:  2017        PMID: 29199383     DOI: 10.1007/s11011-017-0148-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  62 in total

Review 1.  Hippocampal neurogenesis: regulation by stress and antidepressants.

Authors:  Alex Dranovsky; René Hen
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

2.  Noninvasive cortical stimulation enhances motor skill acquisition over multiple days through an effect on consolidation.

Authors:  Janine Reis; Heidi M Schambra; Leonardo G Cohen; Ethan R Buch; Brita Fritsch; Eric Zarahn; Pablo A Celnik; John W Krakauer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

3.  Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism.

Authors:  Christiaan H Vinkers; Marian Joëls; Yuri Milaneschi; René S Kahn; Brenda W J H Penninx; Marco P M Boks
Journal:  Depress Anxiety       Date:  2014-04-17       Impact factor: 6.505

Review 4.  Depression and cognition in the elderly.

Authors:  Sophia Wang; Dan G Blazer
Journal:  Annu Rev Clin Psychol       Date:  2015-01-12       Impact factor: 18.561

5.  Cognitive disturbance comparison among drug-naïve depressed cases and healthy controls.

Authors:  M Iqbal Afridi; Mehwish Hina; Imran Samad Qureshi; Musarrat Hussain
Journal:  J Coll Physicians Surg Pak       Date:  2011-06       Impact factor: 0.711

6.  Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats.

Authors:  P S Coburn-Litvak; K Pothakos; D A Tata; D P McCloskey; B J Anderson
Journal:  Neurobiol Learn Mem       Date:  2003-07       Impact factor: 2.877

7.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

8.  Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.

Authors:  K Hirani; R T Khisti; C T Chopde
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

9.  The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms.

Authors:  Katie J McLaughlin; Juan L Gomez; Sarah E Baran; Cheryl D Conrad
Journal:  Brain Res       Date:  2007-06-02       Impact factor: 3.252

Review 10.  Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations.

Authors:  Janine D Flory; Rachel Yehuda
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

View more
  5 in total

1.  Corticosterone Induced the Increase of proBDNF in Primary Hippocampal Neurons Via Endoplasmic Reticulum Stress.

Authors:  Yu Liu; Guang-Jing Zou; Bo-Xuan Tu; Zhao-Lan Hu; Cong Luo; Yan-Hui Cui; Yang Xu; Fang Li; Ru-Ping Dai; Fang-Fang Bi; Chang-Qi Li
Journal:  Neurotox Res       Date:  2020-05-06       Impact factor: 3.911

2.  PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice.

Authors:  Xiao-Qing Wang; Lei Zhang; Zhong-Yuan Xia; Jia-Yin Chen; Yiru Fang; Yu-Qiang Ding
Journal:  Transl Psychiatry       Date:  2021-03-26       Impact factor: 6.222

3.  Magnetic resonance imaging features of hippocampus and mechanism of neurocognitive dysfunction for antiepileptic drugs in treatment of depression rats.

Authors:  Tuxiu Xie; Ran Li; Xiaobing Long; Jun Chen; Lu Ye; Jing Wang; Guijun Jiang; Jingjun Lv
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Neuroscience education and research in Cameroon: Current status and future direction.

Authors:  Ngala Elvis Mbiydzenyuy; Constant Anatole Pieme; Richard E Brown; Carine Nguemeni
Journal:  IBRO Neurosci Rep       Date:  2021-03-05

5.  Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome.

Authors:  Zehui He; Rong Fan; Chunhu Zhang; Tao Tang; Xu Liu; Jiekun Luo; Hanjin Cui; Yang Wang; Ruohuang Lu; Pingping Gan
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-31       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.